Latest Anatomical pathology Stories
New findings validate clinical utility in Colorectal Cancer Staging MONTREAL, May 16, 2013 /PRNewswire/ - DiagnoCure Inc. (TSX: CUR) (OTCQX: DGCRF) (the "Corporation"), today announced that results from a large validation study of the Previstage(TM) GCC Colorectal Cancer Staging Test have been selected for presentation at the 2013 American Society of Clinical Oncology((R)) (ASCO((R))) Annual Meeting, taking place in Chicago, Illinois from May 31 to June 4, 2013. The results of the...
The new realities of ongoing anatomic pathology (AP) laboratory reimbursement cuts figured prominently in the topics discussed at the recent Executive War College in April. One of the ways labs across the country are addressing financial pressure is through Lean Process Improvement, which is included in NovoPath's AP lab management system. Princeton, NJ (PRWEB) May 15, 2013 Deep, wide and all-encompassing—the new realities of ongoing anatomic pathology (AP) laboratory reimbursement...
HOUSTON, May 15, 2013 /PRNewswire/ -- ApoCell, Inc. announced that the first prototypes of its ApoStream(TM) circulating tumor cell (CTC) isolation system have been delivered to select investigator sites including SAIC-Frederick Inc. (SAIC-F) in support of the National Cancer Institute (NCI). The delivery is part of a $2.9 million subcontract awarded to ApoCell in Q1-2011 by SAIC-F to develop a device capable of isolating live cancer cells from small volumes of blood. While...
NovoPath, Inc. this month marks its 20th year of delivering industry leading management and reporting software solutions to anatomic pathology (AP) providers, after experiencing double-digit growth in 2012, a year marked by far-reaching business challenges. Princeton, NJ (PRWEB) May 03, 2013 NovoPath, Inc., this month, marks its 20th year of delivering industry leading management and reporting software solutions to anatomic pathology (AP) providers, after experiencing double-digit growth...
UCL's Mark Emberton, MD, to Direct Premier Training Center for the Use of Advanced Imaging Capabilities to Localize Cancer and Deliver HIFU Treatment Using Tissue Preserving Techniques CHARLOTTE, N.C., May 2, 2013 /PRNewswire/ -- SonaCare Medical, a global leader in minimally invasive HIFU technologies, announced today that it has partnered with University College London (UCL) to create a HIFU Center of Excellence. The Center of Excellence will provide physician training and...
Sonatherm is the Only Laparoscopic HIFU Device Cleared for Ablating Soft Tissue in the U.S. CHARLOTTE, N.C., May 2, 2013 /PRNewswire/ -- SonaCare Medical, a leader in minimally invasive high intensity focused ultrasound (HIFU) technology, announced today that it will launch the FDA-Cleared Sonatherm(®) HIFU Surgical Ablation System at the the 108(th) Annual Meeting of the American Urological Association (AUA), in San Diego, May 4-8, 2013 (booth #3611). A state-of-the-art...
LEWISVILLE, Texas, May 1, 2013 /PRNewswire/ -- med fusion, Pathologists Bio-Medical Laboratories (PBM) and Theranostics Health will be introducing the first of Theranostics Health's TheraLink(TM) Assays for use in patients with malignant diseases at the upcoming American Society of Clinical Oncology (ASCO) Annual '13 Meeting, held in Chicago, IL from May 30,( )2013 through June 4, 2013. The TheraLink(TM) HER Family Assay for primary, recurrent and metastatic breast cancers provides a...
SmartTarget Offers a Clinically Tested and Practical Solution for MRI-Ultrasound Fusion CHARLOTTE, N.C. and LONDON, April 30, 2013 /PRNewswire/ -- SonaCare Medical, a global leader in minimally invasive High-Intensity Focused Ultrasound (HIFU) technologies, and UCL Business PLC (UCLB), a leading technology transfer company that supports and commercializes research and innovations from UCL (University College London), today announced a partnership to integrate SmartTarget image...
Voices Against Brain Cancer (VABC) responds to an article posted by Cancer Research UK detailing key cancer research New York, NY (PRWEB) April 26, 2013 On April 26, Voices Against Brain Cancer (VABC) responds to an article posted by Cancer Research UK detailing how researchers may have discovered a new tactic that will help predict whether or not cases of breast cancer will spread to the brain. The Cancer Research UK article states that a team of researchers based at Baylor College of...
Women who had sufficient amounts of vitamin D were 32 percent less likely to develop fibroids than women with insufficient vitamin D, according to a study from researchers at the National Institutes of Health. Fibroids, also known as uterine leiomyomata, are noncancerous tumors of the uterus. Fibroids often result in pain and bleeding in premenopausal women, and are the leading cause of hysterectomy in the United States. The study of 1,036 women, aged 35-49, living in the Washington,...
Latest Anatomical pathology Reference Libraries
The Indian Journal of Dermatology, Venereology and Leprology (IJDVL) is a peer-reviewed open-access medical journal published bimonthly on behalf of the Indian Association of Dermatologists, Venereologists and Leprologists. It was established in 1940 and the current editor-in-chief is D.M. Thappa (as of May 2012). The journal reaches more than 6,000 members of the IADVL as well as nearly 200 medical colleges in India. The journal focuses on articles on clinical and experimental...
Merkel cell polyomavirus (MCV or MCPyV), first discovered in January 2008, is one of seven human tumor viruses. It is suspected to cause most of Merkel cell carcinoma which is a rare, aggressive form of skin cancer. Around 80% of Merkel cell carcinoma tumors are found to be infected with MCV. It is found in respiratory secretions suggesting that it may be transmitted by a respiratory route. Usually the tumors with MCV viruses go through at least two mutations that render the virus...
